近日，山东新希望六和集团有限公司（下称"山东六和"）股东及主要成员发生变更。中信金融资产退出山东六和，退出前在山东六和的认缴出资为2.64亿 元，持股比例为6.47%。 中信金融资产退出山东六和，曾认缴出资2.64亿元 企查查信息显示，山东新希望六和集团有限公司（下称"山东六和"）近日股东及主要成员发生变更。 | 股东 | 变更前 | | 变更后 | | | --- | --- | --- | --- | --- | | | 持股比例 | 认缴金额 | 持股比例 | 认缴金额 | | 新希望六和股份有限公司 | 93.5299% | 381176.4705万元 | 100% | 407544.993182万元 | | 股东 | 退出前(持股比例) | | --- | --- | | 中国中信金融资产管理股份有限公司 | 6.4701% | 山东六和的高管及市场主体类型也进行了变更。仲芳接替冉佳炫担任山东六和董事，山东六和的市场主体类型由其他有限责任公司变更为有限责任公司， 非自然人投资或控股的法人独资。 企查查显示，仲芳除担任山东六和董事外，还担任新希望六和饲料股份有限公司（下称"六和饲料"）董事。 山东六和 ...

Core Viewpoint - China National Pharmaceutical Group announced the transfer of 25% equity in China National Medicine Co., Ltd. to Shanghai Tianyue Tenghua Trading Service Co., Ltd., resulting in no remaining equity or control relationship between the parties involved [1][2]. Summary by Sections Equity Transfer - The equity transfer will be completed by September 30, 2025, in the national property management information system, after which China National Medicine will no longer hold any shares in the pharmaceutical materials company [1][2]. Historical Context - China National Medicine was a founding shareholder of the pharmaceutical materials company, which may still be reflected in public records, leading to potential misinterpretations by the public and investors [2]. Unauthorized Use of Assets - The pharmaceutical materials company has repeatedly used the trademarks and intangible assets of China National Pharmaceutical Group without authorization, constituting serious infringement, and legal actions have been initiated to pursue accountability [3]. Legal Actions and Warnings - The company demands the immediate cessation of any unauthorized use of its trademarks and assets by the pharmaceutical materials company and warns of legal consequences for any impersonation or false association with China National Pharmaceutical Group [3].

Core Viewpoint - Shandong Dongyue Future Hydrogen Energy Materials Co., Ltd. (referred to as Future Materials) has restarted its IPO process and submitted its application to the Shanghai Stock Exchange after previous attempts failed due to various issues [1][2]. Company Background - Future Materials was established in December 2017 with a registered capital of 100 million yuan, co-founded by Huaxia Shenzhou, Xinhua Group, and Beijing Xuri Xinglong, each holding 40%, 30%, and 30% respectively [1]. - The company underwent a significant change in its shareholding structure, with Dongyue Fluorosilicon Technology Group becoming the largest shareholder with a 31.21% stake [2]. Shareholding Structure - As of early 2022, the combined control of Future Materials was held by Fu Jun and his daughter Fu Shuangshuang, who together controlled 72.88% of the voting rights [3]. - Following a series of share transfers and changes in control, Zhang Jianhong regained control of Future Materials, with his entities holding a total of 36.19% of the voting rights by August 2022 [3]. Recent Developments - In June 2023, Fu Shuangshuang transferred 64% of her shares in a related entity, which has led to legal disputes regarding the validity of the transfer [4]. - The restructuring plan for Xinhua Group was approved in February 2024, leading to significant share transfers involving Future Materials [4]. Current Control - Zhang Jianhong is currently the actual controller of Future Materials, holding a total of 35.50% of the voting rights through various entities [5]. - The shareholding is relatively dispersed, with 45 shareholders as of the signing of the prospectus, and the largest shareholder being Beijing Xuri Xinglong with a 22.02% stake [9][10].